This inventor holds 1 USPTO granted patent. Top assignee: University of Alberta. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Alan Michael Downey: Innovator in Protein Tyrosine Phosphatase Inhibitors
Introduction
Alan Michael Downey is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of biochemistry, particularly in the development of methods and systems for preparing irreversible inhibitors of protein tyrosine phosphatases. His innovative work has implications for peptide synthesis and the identification of specific protein sequences.
Latest Patents
Alan Michael Downey holds a patent for "Methods and systems for preparing irreversible inhibitors of protein tyrosine phosphatases." This patent describes the preparation and use of novel bromo-phosphonomethylphenylalanine amino acid derivatives (BrPmp) and BrPmp-containing peptides as specific, irreversible protein tyrosine phosphatase inhibitors. These derivatives are advantageous due to their easy and scalable synthesis, making them suitable for peptide synthesis. The BrPmp derivatives can be protected for solid phase peptide synthesis (SPPS) and incorporated into peptides for the preparation of protein tyrosine phosphatase inhibitors and inhibitor libraries. The resulting peptides and libraries can be utilized to identify new protein tyrosine phosphatase specific sequences and profile protein tyrosine phosphatase activity in various samples.
Career Highlights
Alan Michael Downey is affiliated with the University of Alberta, where he continues to advance research in his field. His work has garnered attention for its potential applications in diagnostics and therapeutic development.
Collaborations
Some of his notable coworkers include Christopher Warren Cairo and Naresh Singh Tulsi. Their collaborative efforts contribute to the ongoing research and development in the area of protein tyrosine phosphatase inhibitors.
Conclusion
Alan Michael Downey's innovative contributions to the field of biochemistry, particularly in the development of irreversible inhibitors of protein tyrosine phosphatases, highlight his role as a significant inventor. His work not only advances scientific understanding but also opens new avenues for therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
